Fig. 2
From: Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
IFNγ production in response to EBV and CMV antigens in patients with cancer and in healthy donors. a, b Absolute values of the CMV-pp65 and EBNA-1-specific IFNγ production for each group. c, d Relative IFNγ production against CMV-pp65 and EBNA-1 antigens for each group. Kruskal–Wallis test followed by Dunn’s post-test was performed to gauge statistical significance *p < 0.05; **p < 0.01; ***p < 0.001. Box stars indicate statistical significance of IFNγ production with all the other groups. GBM glioblastoma multiforme, A astrocytoma, OA/OD oligoastrocytoma/oligodendroglioma, M metastatic disease, Panc Cancer pancreatic cancer and HD healthy donor